Mansuo L Shannon

Mansuo L Shannon currently serves as a Board Member and Chief Scientific Officer at Asklepios BioPharmaceutical, Inc. since April 2024. Prior to this role, Mansuo held senior positions at Prevail Therapeutics, a subsidiary of Eli Lilly, from June 2021 to April 2024, including Site Head, Chief Scientific Officer, and Vice President of Research. From 2012 to June 2021, Mansuo worked at Eli Lilly and Company in various roles, such as Senior Director and Research Fellow. Earlier experience includes positions at Chugai Pharmaceutical/Roche Group and Merck, where Mansuo served in leadership roles in research and development. Mansuo holds a PhD in Molecular Biology from Princeton University and completed postdoctoral studies in Neuroscience at the Massachusetts Institute of Technology.